New immunotherapies can dramatically defeat cancer. But more often, cancer evades them, and doctors need to know quickly when that
Day: April 5, 2019
Vitamin B12 is identified as the inhibitor of a key enzyme in hereditary Parkinson’s disease
Parkinson’s is the most common, chronic neurodegenerative movement disorder affecting 1% of the global population over seventy years of age.
Parkinson’s clues seen in tiny fish could aid quest for treatments
Parkinson’s patients could be helped by fresh insights gained from studies of tiny tropical fish. Research using zebrafish has revealed
Fighting ‘superbugs’ with blue light
Antibiotic resistance is a growing concern throughout the world. A recent study investigates whether blue light can destroy these ‘superbugs.’
Computational model of a human kinase may provide insights for cancer treatment
Researchers have developed a computational model for human MEK1, a protein with potential as a drug target for a variety
To keep the creative juices flowing, employees should be receptive to criticism
Attention managers: the next time you need to inspire your team creatively, be more attentive to your employees’ feelings when
Bacterial factories could manufacture high-performance proteins for space missions
Nature has evolved protein-based substances with mechanical properties that rival even the best synthetic materials. For example, pound for pound,
What to know about female sex hormones
Summary description Female sex hormones, or sex steroids, play crucial roles in sexual development, sexual desire, and reproduction. They also
Blocking epigenetic Swiss army knife may be a new strategy for treating colorectal cancer
A new study out today in Cancer Cell shows that blocking specific regions of a protein called UHRF1 switches on
Cancer exports molecular ‘saboteurs’ to remotely disarm immune system
Immunotherapy drugs known as checkpoint inhibitors have revolutionized cancer treatment: many patients with malignancies that until recently would have been
